Abiopharma

🔍 Laurencio Francis (Executive)

Company: Atomera Inc (ATOM)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Sold 2,515 shares of Common Stock at $4.05 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 250,838.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,020 shares of Common Stock at $4.05 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 249,818.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,085 shares of Common Stock at $4.05 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 247,733.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 884 shares of Common Stock at $4.05 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 246,849.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants that were previously reported. This sale is to satisfy mandatory non-discretionary tax withholding obligations by a "sell to cover" transaction pursuant to Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act.